Last updated on April 2017

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation
  • Age: Between 21 - 100 Years
  • Gender: Male or Female
  • Other:
    Fibrillation) with electrocardiographic documentation or patients with prevalent (existing
    diagnosis) AF who had initiation or transition to a FXa (Factor Xa) inhibitor or a direct
    thrombin inhibitor within the preceding 3 months - anticipated ability to adhere to local
    regularly scheduled follow-up visits

You may not be eligible for this study if the following are true:

  • Atrial flutter only - Anticipated life expectancy less than 6 months - short lasting
    AF secondary to a reversible condition (e.g. hyperthyroidism, pulmonary embolism,
    post-cardiothoracic surgery) - Participation in a randomized trial of anticoagulation
    for AF at the time of enrollment - Was enrolled in the ORBIT-I Registry

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.